The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to ...

Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...

House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for ...

Known as the 'man with the golden arm', James Harrison's blood contained a rare antibody that saved millions of lives.

Before anti-D was discovered, HDFN killed more infants than almost any other disease and caused lifelong disability. Up to one in six newborns were at risk, amounting to 40,000 babies every year ...

Harrison, whose plasma contained a rare antibody, rolled up his sleeve 1,173 times from 1954 to 2018. The Australian is credited with helping 2.4 million babies and advancing scientific research.

Learn more about a Coombs test and how it is used as part of standard prenatal screening in the U.S. to detect HDFN.

While it is impossible to know how many babies would have died without Anti-D protection, HDFN affected as many as 1 in 100 women until 1966, government data shows. Following the success of a 1966 ...

James Harrison, whose blood contained a rare antibody used to make lifesaving medication, is credited with saving the lives of more than 2 million babies with his nearly 1,200 donations. He died ...